NASDAQ: LABTLakewood Amedex Biotherapeutics Inc Stock Ownership - Who owns Lakewood Amedex Biotherapeutics?
Insider buying vs selling
Have Lakewood Amedex Biotherapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when LABT insiders and whales buy or sell their stock.
LABT Shareholders
What type of owners hold Lakewood Amedex Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Peter Ceccacci | 66.92% | 468,148 | $1.24M | Insider |
| Kelvin Cooper | 42.97% | 300,594 | $793.57k | Insider |
| Thomas Balzer | 36.50% | 255,322 | $674.05k | Insider |
| Leonard James Deroma | 26.84% | 187,736 | $495.62k | Insider |
| Joseph Edward Tucker | 0.00% | 0 | $0.00 | Insider |
LABT vs Biotech Stocks
Lakewood Amedex Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.